Gene silencing mediated by small interfering RNAs in mammalian cells
- PMID: 12570711
- DOI: 10.2174/0929867033368493
Gene silencing mediated by small interfering RNAs in mammalian cells
Abstract
RNA interference (RNAi) as a protecting mechanism against invasion by foreign genes was first described in C. elegans and has subsequently been demonstrated in diverse eukaryotes such as insects, plants, fungi and vertebrates. RNAi is the mechanism of sequence-specific, post-transcriptional gene silencing initiated by double-stranded RNAs (dsRNA) homologous to the gene being suppressed. dsRNAs are processed by Dicer, a cellular ribonuclease III, to generate duplexes of about 21 nt with 3'-overhangs (small interfering RNA, siRNA) which mediate sequence-specific mRNA degradation. In mammalian cells siRNA molecules are capable of specifically silencing gene expression without induction of the unspecific interferon response pathway. Thus, siRNAs have become a new and powerful alternative to other genetic tools such as antisense oligonucleotides and ribozymes to analyze loss-of-function phenotypes. Application of siRNA duplexes to interfere with the expression of a specific gene requires knowledge of target accessibility, highly effective delivery of siRNAs into target cells and for some applications long-term siRNA expression. Effective strategies to deliver siRNAs to target cells in cell culture include transduction by physical or chemical transfection. An alternative strategy uses the endogenous expression of siRNAs by various Pol III promoter expression cassettes that allow transcription of functional siRNAs or their precursors. This review summarizes some genetic and biochemical aspects of RNAi, the delivery and application of siRNAs to target cells, the kinetics of RNAi and the utility of siRNAs as analytical and potential therapeutic tools.
Similar articles
-
RNA interference: the molecular immune system.J Mol Histol. 2004 Aug;35(6):545-53. doi: 10.1007/s10735-004-2192-8. J Mol Histol. 2004. PMID: 15614608 Review.
-
Expressing functional siRNAs in mammalian cells using convergent transcription.BMC Biotechnol. 2003 Nov 6;3:21. doi: 10.1186/1472-6750-3-21. BMC Biotechnol. 2003. PMID: 14604435 Free PMC article.
-
RNA interference (RNAi) in hematology.Ann Hematol. 2004 Jan;83(1):1-8. doi: 10.1007/s00277-003-0759-1. Epub 2003 Oct 22. Ann Hematol. 2004. PMID: 14574462 Review.
-
The ins and outs of RNAi in mammalian cells.Curr Pharm Biotechnol. 2004 Oct;5(5):441-50. doi: 10.2174/1389201043376643. Curr Pharm Biotechnol. 2004. PMID: 15544492 Review.
-
Small RNA: can RNA interference be exploited for therapy?Lancet. 2003 Oct 25;362(9393):1401-3. doi: 10.1016/S0140-6736(03)14637-5. Lancet. 2003. PMID: 14585643 Review.
Cited by
-
Update on human genome completion and annotations: gene nomenclature.Hum Genomics. 2003 Nov;1(1):66-71. doi: 10.1186/1479-7364-1-1-66. Hum Genomics. 2003. PMID: 15601535 Free PMC article.
-
Cell-specific RNA interference by peptide-inhibited-peptidase-activated siRNAs.J RNAi Gene Silencing. 2010 Dec 31;6(2):422-30. J RNAi Gene Silencing. 2010. PMID: 21350683 Free PMC article.
-
Deoxyribozymes and bioinformatics: complementary tools to investigate axon regeneration.Cell Tissue Res. 2012 Jul;349(1):181-200. doi: 10.1007/s00441-011-1291-6. Epub 2011 Dec 22. Cell Tissue Res. 2012. PMID: 22190188 Free PMC article. Review.
-
Polymerase synthesis and potential interference of a small-interfering RNA targeting hPim-2.World J Gastroenterol. 2004 Sep 15;10(18):2657-60. doi: 10.3748/wjg.v10.i18.2657. World J Gastroenterol. 2004. PMID: 15309714 Free PMC article.
-
Novel animal models for studying complex brain disorders: BAC-driven miRNA-mediated in vivo silencing of gene expression.Mol Psychiatry. 2010 Oct;15(10):987-95. doi: 10.1038/mp.2010.1. Epub 2010 Feb 2. Mol Psychiatry. 2010. PMID: 20125089 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials